IP Library › Granted Patent US 7,067,620
Granted Patent B2
US 7,067,620 · App. 10/274,557 · Granted Jun 27, 2006

Antibacterial agents

Assignee: Theravance, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,067,620
App. No.
10/274,557
Granted
Jun 27, 2006
Kind
B2
Abstract

Novel antibacterial agents that act as multibinding agents are disclosed. The compounds of the invention comprise from 2–10 ligands covalently connected, each of said ligands being capable of binding to a transglycosylase enzyme substrate thereby modulating the biological processes/functions thereof.

Claims (6)

1. A compound of the formula:

wherein

R is a hydrogen or 9-fluorenylmethoxycarbonyl;

or a pharmaceutically-acceptable salt thereof.

2. The compound according to claim 1 , wherein R is hydrogen.

3. The compound according to claim 1 , wherein R is 9-fluorenylmethoxycarbonyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033162/0474 →
Continuity (6)
Continuation 0925367000 · Feb 19, 1999
Provisional Application 6007551400 · Feb 20, 1998
Provisional Application 6007890300 · Mar 20, 1998
Provisional Application 6008220900 · Apr 17, 1998
Provisional Application 6011916200 · Feb 8, 1999
Related Publication 20050171010A1 · Aug 4, 2005